Lewes, DE -- (SBWIRE) -- 09/07/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Ciena Corporation (NASDAQ:CIEN), Ariad Pharmaceuticals, Inc.(NASDAQ:ARIA), American Capital Agency Corp.(NASDAQ:AGNC), Mylan Inc (NASDAQ:MYL).
Ciena Corporation(NASDAQ:CIEN) ended higher +2.50% and complete the day at $24.15. The total number of shares changed hands during the day was 6.87 million. After opening at $23.91, the stock hit as high as $24.61. However, it traded between $11.95 and $24.61 over the last twelve months.
Ciena Corporation provides communications networking equipment, software, and services that support the transport, switching, aggregation, and management of voice, video, and data traffic worldwide.
For How Long CIEN will Fight for Profitability? Read This Trend Analysis report
Ariad Pharmaceuticals, Inc.(NASDAQ:ARIA) closed yesterday at $22.31, a +7.52% increase. Around 6.25 million shares were traded, beating an-average trading volume of 2.39 million shares. The company is now valued at around $4.13 billion.
ARIAD Pharmaceuticals, Inc., an oncology company, focuses on the discovery, development, and commercialization of medicines for cancer patients.
For How Long ARIA Gloss will Attract Investors? Find out via this report
American Capital Agency Corp.(NASDAQ:AGNC) moved +2.16 percent higher at $22.74 and traded between $22.54 and $22.89 after opening the day at $22.70. Its performance over the last five days remained -0.35%, which stands at 1.02% for a month. Going back further than one month, 1-year performance after recent close was -21.31%.
American Capital Agency Corp. operates as a real estate investment trust (REIT). It invests in residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by government-sponsored entities or by the United States government agency.
For How Long AGNC Gloss will Attract Investors? Find out via this report
Mylan Inc(NASDAQ:MYL) shares fall, losing -1.63 percent to close at $35.29. The stock is up around 28.56% this year and 49.72% for the last 12 months. Around 5.33 million shares changed hands yesterday, higher from an-average trading volume of 4.31 million shares.
Mylan Inc. engages in the development, manufacture, marketing, licensing, and distribution of generic and branded generic pharmaceuticals, specialty pharmaceuticals, and active pharmaceutical ingredients (APIs) worldwide. It operates in two segments, Generics and Specialty.
Will MYL Get Buyers Even After The Recent Rally? Find Out Here
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)